Multimédia

Photos

Vidéos

• 

  Les traitements innovants sont le résultat d'années de passion, d'expertise et de dévouement pour les individus. Les employés du secteur biopharmaceutique belge témoignent de leur engagement à aider les patients.

• 
• 
• 

  Jean-Georges Compère participated to a clinical trial. He speaks about his patient experience.

• 

  Kristel De Gauquier - Medical Director pharma.be : " Les maladies rares sont un défi pour l'industrie pharmaceutique"

• 

  Vidéo de la campagne d'information #LeCombatContinue

• 

  Catherine Rutten, CEO pharma.be, explique la campagne d'information #LeCombatContinue

• 

  Clinical Trial Forum Part II - Interviews with Catherine Rutten (CEO pharma.be), Liesbeth Moortgat (AS Delta), PR. Sylvie Rottey (UZ Ghent).

• 

  Clinical Trial Forum - Part I - Interviews with Catherine Rutten (CEO pharma.be), Jean-Pierre Latere (Celyad), PR. François Duhoux (UCL St Luc)

• 

  Compilation movie - pharma.be Dialogue 2017

• 

  Dialogue 2017: interview with Manuella Wilts. Director costumer services EMEA Johnson&Johnson

• 

  Dialogue 2017: interview with Herman De Croo. Minister of State

• 

  Dialogue 2017: interview with Sonja Willems. Chairwoman pharma.be.

• 

  Dialogue 2017: interview with Dirk Lannoo. V.P. Katoen Natie.

• 

  Dialogue 2017: interview with Gert Bervoets. CEO ESSERS.

• 

  Dialogue 2017: interview with Pascale Delcomminette. CEO Wallonia Foreign Trade and Investment Agency (AWEX)

• 

  Dialogue 2017: interview Catherine Rutten. CEO pharma.be.

• 

  N-SIDE: bringing forecasting, simulation & optimization solutions to pharma

• 

  Lieven Zwaenepoel (APB): Digital innovation in community pharmacies

• 

  Federal Agency inspections for quality and safe medicines (famhp)

• 

  The journey of a medicine: from production to delivery to patients

• 

  Dr. Isabelle Huyghe, Senior Clinical Research physician at Pfizer, describing the importance of clinical trials and volunteering.

• 

  Mario, a clinical trial volunteer, about his motivations to participate to a clinical trial study.

• 

  Anna Colzi, Medical Director at Pfizer's phase 1 unit at the Erasmus hospital in Brussels, is describing the patients" engagement to clinical trials.

• 

  50 years of pharma.be Symposium (compilation)

• 

  "New perspectives in Hepatitis C treatment" - Véronique Scaillon

• 

  "Improved quality of life of Psoriasis patients" - Paul De Corte

• 

  "Innovations give hope to pancreatic cancer patients" - Leo Coene

• 

  "How HIV became a treatable, chronic disease" - Patrick Reyntiens

• 

  Xavier De Cuyper (famhp) : "Preserving the Belgian leadership in clinical trials in Europe"

• 

  Facts & figures on the Belgian Pharma Valley

• 

  Belgium's contribution to therapeutic innovation through the past decades

• 

  Proud to be part of pharma : Francis' role within Zoetis, is development and production of new vaccines for animals. Follow on Twitter: #pharmafaces

• 

  "Proud to be part of pharma" : Tom (AbbVie) looks to develop new,innovative solutions to support patients with chronic diseases in their treatment process. Follow on Twitter: #pharmafaces

• 

  "Proud to be part of pharma" : After a five-year career as a general practitioner, Dr. Paul Lacante made the switch to the pharmaceutical industry and is now Medical Director. Follow on Twitter: #pharmafaces

• 

  "Proud to be part of pharma" : Ingrid (UCB) works closely with a team of MSL's that gives scientific support to physicians. Follow on Twitter : #pharmafaces

• 

  Nathan De Valck works for the Brussels Airport Company in the Cargo Management team. Brussels Airport stands out for its dedicated infrastructure to transport medicines. Follow on Twitter : #pharmafaces

• 

  "Proud to be part of pharma" : Alain-Geert works in the production department of Genzyme, a biotech company that is part of Sanofi. Follow on Twitter : #pharmafaces

• 

  "Proud to be part of pharma" : Ellen is a Customer Service Representative at Pfizer. Her objective is to deliver innovative medicines as quick as possible to patients in need, worldwide. Follow on Twitter : #pharmafaces

• 

  "Proud to be part of pharma" : As a Market Access Manager for GSK, Catheline acts after a medicine has been registered. She is responsible for submitting applications for price & reimbursement. Follow on Twitter : #pharmafaces

• 

  "Proud to be part of pharma" : Working as a Regulatory Affairs Manager for the pharmaceutical company MSD Belgium, Laurence is responsible for the approval process of the registration of new medicines. follow on Twitter : #pharmafaces

• 

  "Proud to be part of pharma" : Anne-Sophie is a Clinical Research Associate (CRA) for the pharmaceutical company Novo Nordisk. Her main task is to start up, follow up and close clinical trials. follow on Twitter : #pharmafaces

• 

  "Proud to be part of pharma" : Ole works for Janssen Pharmaceutica in Belgium, as a Principal Research Scientist in the R&D group. His expertise lies mainly in the world of personalised pharmaceutical development. Follow on Twitter : #pharmafaces

• 

  Catherine Rutten, CEO pharma.be - speech at Dialogue @pharma.be 2016

• 

  Interview with Sjaak De Boer (Cordaid) at the Dialogue @pharma.be 2016

• 

  Interview with Prof. dr. Marleen Temmerman at the Dialogue @pharma.be 2016

• 

  Interview with Eduardo Pisani @ the Dialogue @pharma.be 2016

• 

  Interview with Jaak Peeters (J&J) at the Dialogue @pharma.be 2016

• 

  Sonja Willems, Chairwoman of the Board of pharma.be - speech at the Dialogue @pharma.be 2016

• 

  Dialogue @pharma.be 2016 (produced by Mevipro)

• 

  Luc Debruyne, President & General Manager of GSK Vaccines - speech at the Dialogue @pharma.be 2016

• 

  Interview with An-Heleen De Greef, Philanthropy Manager, Doctors of the World Belgium

• 

  Interview with Sam Proesmans, Doctor in Internal Medicine

• 

  Interview with Dr Adrian Hopkins, Director Mectizan Donation Program

• 

  Interview with Dr Dirk Teuwen, VP Corporate Societal Responsibility, UCB

• 

  Interview with Michael Leniere, Project Lead Supply Chain Pfizer

• 

  Interview with Dr Dirk D'Hooge , Medical Director Novo Nordisk Pharma

• 

  2015 IFPMA Pharma By Numbers

• 

  EFPIA: What Is The Innovative Medicines Initiative? (IMI)

• 

  LEEM: Pourquoi participer à un essai clinique ?

• 

  EFPIA: Transparency and Privacy

• 

  EFPIA: Clinical Trials and Transparency

• 

  EFPIA: The importance of Clinical Trials

• 

  EFPIA: Designing a Clinical Trial

• 

  EFPIA: The Journey of Clinical Trials

• 

  IFPMA video on awareness of fake medicines

• 

  Le 11 juin 2015, les Mutualités Libres (MLOZ) ont organisé un débat sur 'des médicaments à tout prix?'. Au cours de ce débat, Catherine Rutten, CEO de pharma.be, a souligné les coûts de développement élevés d'un médicament avant la mise sur le marché et les prix bas des médicaments en Belgique par rapport à d'autres pays en Europe.

• 

  EFPIA video: Intellectual Property & the Pharma Industry - Introducing Marty the Medicine

• 

  Catherine Rutten: « Conserver la pole position dans la recherche clinique »

• 

  Catherine Rutten: « Amener les médicaments plus rapidement sur le marché »

• 

  Catherine Rutten (pharma.be): « Le débat sur le prix des médicaments doit être élargi »

• 

  Observance thérapeutique et bon usage des médicaments